Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03277430Phase 3Recruiting
Phase 3, open-label trial (2 arms), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Efficacy of uterus transplantation at 5 years. Started Oct 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03277430.